DEXTROSTAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dextrostat, and what generic alternatives are available?
Dextrostat is a drug marketed by Shire and is included in one NDA.
The generic ingredient in DEXTROSTAT is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dextrostat
A generic version of DEXTROSTAT was approved as dextroamphetamine sulfate by BARR on January 31st, 2001.
Summary for DEXTROSTAT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 17 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEXTROSTAT at DailyMed |
US Patents and Regulatory Information for DEXTROSTAT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shire | DEXTROSTAT | dextroamphetamine sulfate | TABLET;ORAL | 084051-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Shire | DEXTROSTAT | dextroamphetamine sulfate | TABLET;ORAL | 084051-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |